Oil-Dri Announces Issuance of Patent in Europe for Novel Technology Driving Antibiotic-Free Animal Protein Production
August 18 2020 - 1:46PM
Oil-Dri Corporation of America (NYSE: ODC), a leading manufacturer
of sorbent minerals, parent company to Amlan International,
announces that the European Patent Office has issued Patent EP
2906238. The patent covers the unique formulation of two existing
mineral-based natural feed additives, Varium® for poultry and
NeoPrime® for swine, that are helping global animal protein
producers thrive in an era of antibiotic-free production.
This patent will be validated in Belgium, France, Germany, Great
Britain, Hungary, Italy, Poland, Portugal, Spain and Turkey,
bringing the total number of countries to 12 that have issued
patent protection for the mineral-based formula. Earlier this year,
the United States Patent and Trademark Office issued a patent for
the formulations featured in Varium and NeoPrime. China issued a
similar patent in 2018.
The EU patent provides a methodology for using a natural,
mineral-based formula to mitigate the effects of exposure to
pathogenic bacteria and the disease-causing toxins they produce,
which damage gut health and function. Advancements in natural feed
additives are helping to transform animal protein production by
providing proven and reliable alternatives to in-feed antibiotics
used to promote growth and productivity.
“Oil-Dri’s European patent is another indicator for leading
producers and the food industry that mineral-based antibiotic
alternatives can be a value-add to ABF protein production,” said
Daniel S. Jaffee, President and CEO of Oil-Dri Corporation of
America. “We're proud to be on the leading edge of advancements in
natural feed additives that are helping to transform animal protein
production by providing proven and reliable alternatives to in-feed
antibiotics used to promote growth and productivity.”
“Feedback on Varium from partners in the animal health industry
has been incredibly positive,” says Flemming L. Mahs, President of
Amlan International. “Poultry producers and veterinarians report
improved skin quality, fewer incidences of foot pad lesions and
lower mortality rates during transport after incorporating Varium
into feed rations. We are excited to see the industry recognize the
animal health benefits of Varium and NeoPrime, and we will continue
to work toward innovative solutions for livestock and poultry
producers worldwide.”
Mineral-Based Technology
Unlike antibiotics, which are designed to kill bacteria, the
patented technology includes a synergistic formula of three
ingredients with distinct modes of action: (1) a surface-activated
mineral that facilitates chemical binding of pathogenic intestinal
bacteria and the disease-causing toxins they produce, (2) an
immunomodulator that stimulates an animal’s innate immune system to
naturally defend against disease and (3) an energy source to
replenish intestinal epithelial cells that are essential for
healthy gut function. Producers have substituted this patented
technology for other AGP alternatives and improved growth and
efficiency.
Amlan International
Oil-Dri Corporation of America (NYSE: ODC), a Delaware
corporation doing business as “Amlan International,” is a global
leader in proven solutions that improve the intestinal health and
productivity of livestock. Amlan has grown its product offering
across the intestinal health and AGP-alternative market, driven
largely by the research conducted at its laboratory campus in
Vernon Hills, Illinois.
Amlan International sells animal health products outside of the
United States. Product associated claims do not constitute medical
claims and may differ based on government requirements. Product
availability may vary by country.
Reagan CulbertsonMedia Contactpress@amlan.com
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
From Apr 2023 to Apr 2024